BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15823547)

  • 1. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
    Cao W; Chi WH; Wang J; Tang JJ; Lu YJ
    Biochem Biophys Res Commun; 2005 May; 330(4):1034-40. PubMed ID: 15823547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells.
    Shiohara M; Akashi M; Gombart AF; Yang R; Koeffler HP
    J Cell Physiol; 1996 Mar; 166(3):568-76. PubMed ID: 8600160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
    Li W; Fan J; Bertino JR
    Cancer Res; 2001 Mar; 61(6):2579-82. PubMed ID: 11289134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
    Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
    Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.
    Aguero MF; Facchinetti MM; Sheleg Z; Senderowicz AM
    Cancer Res; 2005 Apr; 65(8):3364-73. PubMed ID: 15833870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim CH; Moon SK
    Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1.
    Meng LH; Zhang H; Hayward L; Takemura H; Shao RG; Pommier Y
    Cancer Res; 2004 Dec; 64(24):9086-92. PubMed ID: 15604277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells.
    Lu Y; Tatsuka M; Takebe H; Yagi T
    Mol Carcinog; 2000 Sep; 29(1):1-7. PubMed ID: 11020241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
    Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
    Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined treatment TNF-alpha/doxorubicin alleviates the resistance of MCF-7/Adr cells to cytotoxic treatment.
    Cao W; Ma SL; Tang J; Shi J; Lu Y
    Biochim Biophys Acta; 2006 Feb; 1763(2):182-7. PubMed ID: 16483679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
    Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells.
    Wu J; Harris NL; Inge TH
    J Surg Res; 2004 Dec; 122(2):231-9. PubMed ID: 15555623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction.
    Prabhu NS; Blagosklonny MV; Zeng YX; Wu GS; Waldman T; El-Deiry WS
    Clin Cancer Res; 1996 Jul; 2(7):1221-9. PubMed ID: 9816291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells.
    Lu Y; Yamagishi N; Yagi T; Takebe H
    Oncogene; 1998 Feb; 16(6):705-12. PubMed ID: 9488034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.